drugset / Trial / NCT01296191

Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification

NCT01296191

Phase 4 Completed 120 enrolled Frank A. Bucci, Jr., M.D.
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to compare drug concentrations in aqueous humor following ocular instillation of Besivance and VIGAMOX in subjects undergoing cataract surgery.

Timeline

Start
2011-05
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Besifloxacin Small molecule Other
Comparator Moxifloxacin Small molecule Other

Indications